Donor Testing and Risk: Current Prevalence, Incidence, and Residual Risk of Transfusion-Transmissible Agents in US Allogeneic Donations
Authors:
- Shimian ZouSZShimian Zou
- Susan L. StramerSSSusan L. Stramer
- Roger Y. DoddRDRoger Y. Dodd
- 1 April 2012
- journal article
- review article
- Published by Elsevier in Transfusion Medicine Reviews
- Vol. 26 (2) , 119-128
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Human T‐lymphotropic virus antibody screening of blood donors: rates of false‐positive results and evaluation of a potential donor reentry algorithmTransfusion, 2010
- Prevalence, incidence, and residual risk of major blood‐borne infections among apheresis collections to the American Red Cross Blood Services, 2004 through 2008Transfusion, 2010
- Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testingTransfusion, 2010
- Age‐related donor return patterns among first‐time blood donors in the United StatesTransfusion, 2009
- Current incidence and residual risk of hepatitis B infection among blood donors in the United StatesTransfusion, 2009
- Current value of serologic test for syphilis as a surrogate marker for blood‐borne viral infections among blood donors in the United StatesTransfusion, 2009
- Adverse Reactions to Allogeneic Whole Blood Donation by 16- and 17-Year-OldsJAMA, 2008
- Effectiveness of human T‐lymphotropic virus (HTLV) recipient tracing (lookback) and the current HTLV‐I and ‐II confirmatory algorithm, 1999 to 2004Transfusion, 2006
- Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification TestingNew England Journal of Medicine, 2004
- Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor populationTransfusion, 2002